DexCom (NASDAQ: DXCM) reported Q3 EPS of ($0.04), $0.12 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $184.6 million versus the consensus estimate of $184.22 million.

For earnings history and earnings-related data on DexCom (DXCM) click here.